These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18941464)

  • 41. Cyr61 expression is associated with prognosis in patients with colorectal cancer.
    Jeong D; Heo S; Sung Ahn T; Lee S; Park S; Kim H; Park D; Byung Bae S; Lee SS; Soo Lee M; Kim CJ; Jun Baek M
    BMC Cancer; 2014 Mar; 14():164. PubMed ID: 24606730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors.
    Habel N; Vilalta M; Bawa O; Opolon P; Blanco J; Fromigué O
    Oncogene; 2015 Jun; 34(24):3207-13. PubMed ID: 25065593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A functional polymorphism in the CYR61 (IGFBP10) gene is associated with prostate cancer risk.
    Tao L; Chen J; Zhou H; Qin C; Li P; Cao Q; Li J; Ju X; Zhu C; Wang M; Zhang Z; Shao P; Yin C
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):95-100. PubMed ID: 23045290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nishio M; Takase N; Utsunomiya S; Akiyama H; Kakeji Y; Komori T; Koma Y; Yokozaki H
    Cancer Med; 2015 Mar; 4(3):437-46. PubMed ID: 25620088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
    Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
    Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prohibitin-2 negatively regulates AKT2 expression to promote prostate cancer cell migration.
    Shen Y; Gao Y; Yuan H; Cao J; Jia B; Li M; Peng Y; Du X; Zhang J; Shi J
    Int J Mol Med; 2018 Feb; 41(2):1147-1155. PubMed ID: 29207197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma.
    Wei J; Yu G; Shao G; Sun A; Chen M; Yang W; Lin Q
    Oncotarget; 2016 May; 7(21):31067-78. PubMed ID: 27105510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.
    Bizzarro V; Belvedere R; Migliaro V; Romano E; Parente L; Petrella A
    Cell Adh Migr; 2017 May; 11(3):247-260. PubMed ID: 27834582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
    Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
    Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyr61 increases matrix metalloproteinase-3 expression and cell motility in human oral squamous cell carcinoma cells.
    Chuang JY; Yu NY; Chiang IP; Lai CH; Lin CD; Tang CH
    J Cell Biochem; 2012 Jun; 113(6):1977-86. PubMed ID: 22253074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
    Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
    Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CYR61 suppresses growth of human malignant melanoma.
    Chen J; Liu Y; Sun Q; Wang B; Li N; Chen X
    Oncol Rep; 2016 Nov; 36(5):2697-2704. PubMed ID: 27665942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
    Cai J; Shen G; Liu S; Meng Q
    Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction and function of CYR61 (CCN1) in prostatic stromal and epithelial cells: CYR61 is required for prostatic cell proliferation.
    Sakamoto S; Yokoyama M; Aoki M; Suzuki K; Kakehi Y; Saito Y
    Prostate; 2004 Dec; 61(4):305-17. PubMed ID: 15389821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Production of Cyr61 protein is modulated by extracellular acidification and PI3K/Akt signaling in prostate carcinoma PC-3 cells.
    Lee YJ; Lee DM; Lee SH
    Food Chem Toxicol; 2013 Aug; 58():169-76. PubMed ID: 23623839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
    Chen W; Liu Y; Chen H; Ning H; Ding K
    Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
    Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
    Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
    Wang X; Shi Z; Liu X; Su Y; Li W; Dong H; Zhao L; Li M; Wang Y; Jin X; Huo Z
    J BUON; 2018; 23(2):444-452. PubMed ID: 29745091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Baicalein Inhibits Epithelial to Mesenchymal Transition via Downregulation of Cyr61 and LOXL-2 in MDA-MB231 Breast Cancer Cells.
    Nguyen LT; Song YW; Cho SK
    Mol Cells; 2016 Dec; 39(12):909-914. PubMed ID: 28008161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
    Xiang J; Bian C; Wang H; Huang S; Wu D
    J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.